Myocardial Reperfusion Injury

"Myocardial Reperfusion Injury" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm.

Descriptor ID	D015428
MeSH Number(s)	C14.280.238.615 C14.280.647.625 C14.907.585.625 C14.907.725.600 C23.550.767.877.500
Concept/Terms	Myocardial Reperfusion Injury Myocardial Reperfusion Injury Injuries, Myocardial Reperfusion Myocardial Reperfusion Injuries Reperfusion Injuries, Myocardial Myocardial Ischemic Reperfusion Injury Reperfusion Injury, Myocardial Injury, Myocardial Reperfusion

Below are MeSH descriptors whose meaning is more general than "Myocardial Reperfusion Injury".

Diseases [C]
Cardiovascular Diseases [C14]
Heart Diseases [C14.280]
Cardiomyopathies [C14.280.238]
Myocardial Reperfusion Injury [C14.280.238.615]
Myocardial Ischemia [C14.280.647]
Myocardial Reperfusion Injury [C14.280.647.625]
Vascular Diseases [C14.907]
Myocardial Ischemia [C14.907.585]
Myocardial Reperfusion Injury [C14.907.585.625]
Reperfusion Injury [C14.907.725]
Myocardial Reperfusion Injury [C14.907.725.600]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Postoperative Complications [C23.550.767]
Reperfusion Injury [C23.550.767.877]
Myocardial Reperfusion Injury [C23.550.767.877.500]

Below are MeSH descriptors whose meaning is more specific than "Myocardial Reperfusion Injury".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Myocardial Reperfusion Injury" by people in this website by year, and whether "Myocardial Reperfusion Injury" was a major or minor topic of these publications.

Bar chart showing 43 publications over 22 distinct years, with a maximum of 4 publications in 2007 and 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
2000	1	0	1
2001	1	0	1
2002	1	0	1
2003	2	1	3
2004	1	0	1
2005	1	0	1
2007	4	0	4
2008	0	1	1
2009	2	0	2
2011	2	0	2
2012	3	0	3
2013	1	0	1
2014	2	0	2
2015	4	0	4
2016	1	1	2
2017	1	2	3
2018	0	2	2
2019	3	0	3
2020	1	0	1
2021	1	0	1
2023	3	0	3

Below are the most recent publications written about "Myocardial Reperfusion Injury" by people in Profiles.

Noaman S, Neil C, O'Brien J, Frenneaux M, Hare J, Wang B, Yee Tai T, Theuerle J, Shaw J, Stub D, Bloom J, Walton A, Duffy SJ, Peter KH, Cox N, Kaye DM, Taylor A, Chan W. UpStreAm doxycycline in ST-eLeVation myocArdial infarction: targetinG infarct hEaling and ModulatIon (SALVAGE-MI trial). Eur Heart J Acute Cardiovasc Care. 2023 Apr 03; 12(3):143-152.

View in: PubMed
Sharma S, Sharma P, Subedi U, Bhattarai S, Miller C, Manikandan S, Batinic-Haberle I, Spasojevic I, Sun H, Panchatcharam M, Miriyala S. Mn(III) Porphyrin, MnTnBuOE-2-PyP5+, Commonly Known as a Mimic of Superoxide Dismutase Enzyme, Protects Cardiomyocytes from Hypoxia/Reoxygenation Induced Injury via Reducing Oxidative Stress. Int J Mol Sci. 2023 Mar 24; 24(7).

View in: PubMed
Shimada BK, Yorichika N, Higa JK, Baba Y, Kobayashi M, Aoyagi T, Suhara T, Matsui T. mTOR-mediated calcium transients affect cardiac function in ex vivo ischemia-reperfusion injury. Physiol Rep. 2021 03; 9(6):e14807.

View in: PubMed
Rodr?guez-Graciani KM, Chapa-Dubocq XR, MacMillan-Crow LA, Javadov S. Association Between L-OPA1 Cleavage and Cardiac Dysfunction During Ischemia-Reperfusion Injury in Rats. Cell Physiol Biochem. 2020 Oct 30; 54(6):1101-1114.

View in: PubMed
Escobales N, Nu?ez RE, Javadov S. Mitochondrial angiotensin receptors and cardioprotective pathways. Am J Physiol Heart Circ Physiol. 2019 06 01; 316(6):H1426-H1438.

View in: PubMed
Kobayashi M, Higa JK, Matsui T. The role of ubiquitin in cardiac ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2019 Mar 01; 316(3):H583-H585.

View in: PubMed
Pandey A, Keshvani N, Ayers C, Correa A, Drazner MH, Lewis A, Rodriguez CJ, Hall ME, Fox ER, Mentz RJ, deFilippi C, Seliger SL, Ballantyne CM, Neeland IJ, de Lemos JA, Berry JD. Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study. JAMA Cardiol. 2019 01 01; 4(1):51-58.

View in: PubMed
Nu?ez RE, Javadov S, Escobales N. Critical role of angiotensin II type 2 receptors in the control of mitochondrial and cardiac function in angiotensin II-preconditioned rat hearts. Pflugers Arch. 2018 09; 470(9):1391-1403.

View in: PubMed
Kobayashi M, Suhara T, Baba Y, Kawasaki NK, Higa JK, Matsui T. Pathological Roles of Iron in Cardiovascular Disease. Curr Drug Targets. 2018; 19(9):1068-1076.

View in: PubMed
Baba Y, Higa JK, Shimada BK, Horiuchi KM, Suhara T, Kobayashi M, Woo JD, Aoyagi H, Marh KS, Kitaoka H, Matsui T. Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2018 03 01; 314(3):H659-H668.

View in: PubMed

People

Explore

Similar Concepts

Top Journals